Overview
Status
Active
Registry date
2017-01-23
Share capital
80,000.00 PLN
Registered address
ul. Puławska 392, 02-801 Warszawa, Poland
Electronic delivery address
AE:PL-95147-33275-EVCDD-21
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 52 days early.
- 202512/06/2026
- 202405/06/2025
- 202318/06/2024
- 202228/06/2023
- 202130/05/2022
- 202020/05/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 791.54kMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 47.58kMedianUSD 20.66kAverageUSD 86.55k
Operating costs
This companyUSD 737.07kMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 129.66kMedianUSD 544.32kAverageUSD 1.76m
Industry
National Health Fund (NFZ) contracts
Salpharma has been an NFZ healthcare provider since 2024. In 2026 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 0.00 in total.
NFZ contract value by year (USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Other services provided in pharmacies | mazowieckie | 1 | USD 0.00 |
Authorized Representatives
Anna Maria Salska – President of the Management Board
Manner of representation
Each member of the management board acting independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Przemysław Wojciech Druszczage 58 | 400 | $10,804.97 | 50% |
Anna Maria Salskaage 56 | 400 | $10,804.97 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2017-02-04.
27 1020 1169 0000 8802 0248 8708
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $4,512.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 21, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,038$1,038 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Sep 21, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $881$881 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 23, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Stołecznego Warszawy |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Cosmedicasp. z o.o. | $49,355,260.75 | cosmedica.pl | ||
| DR ZdrowieS.A. | $40,415,498.47 | drzdrowie.pl | ||
| MagmaxS.A. | $4,200,912.15 | magmaxsa.pl | ||
| Novopharm - Millersp. j. | $2,839,228.36 | apteka.zyj-zdrowo.com | ||
| MaglowS.A. | $1,356,219.12 | maglow.pl | ||
| Farmacja Im. O. Klimuszkisp. z o.o. | $1,289,548.20 | zyj-zdrowo.com | ||
| Nukloversp. z o.o. | $227,479.26 | nuklover.com | ||
| Massmedsp. z o.o. | $49,747.70 | mojoapps.co | ||
| DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A. | $2,740.83 | kwendasa.pl | ||
| Femaherbsp. z o.o. | $655.76 | femaherb.com |
Change history
| Date | Event | |
|---|---|---|
| 2017-08-09 | Address change (Ul. Stefana Bryły 10/55, 02-685, Warszawa → Ul. Puławska 392, 02-801, Warszawa) | |
| 2017-01-23 | Entered in the register |
FAQ
The main business activity of Salpharma focuses on dispensing chemist in specialised stores.
The company was registered in the Polish National Court Register (KRS) on January 23, 2017.
The headquarters is located at: ul. Puławska 392, 02-801 Warszawa.
The share capital of the company is PLN 80,000 (approx. $21,610).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of $791,544 in 2025, which is an increase of 10.4% compared to 2024.
Yes, in 2025 the company was profitable, achieving a net profit of $47,577, meaning the company decreased its profit by 17.3%.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $584,605 in 2025, representing 79% of all operating expenses.
Last updated: 2026-06-12